Screener
Co-Diagnostics, Inc. CODX Q1 2026 Annual earnings
Reported May 14, 2026 · After market close
Revenue$146.0KBeat by $18.9K
EPS-$4.06Miss by $0.31
Revenue estimate$127.1K
EPS estimate-$3.75
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$169.0K
EPS estimate-$1.25
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Co-Diagnostics, Inc. report Q1 2026 earnings?
- Co-Diagnostics, Inc. (CODX) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were Co-Diagnostics, Inc.'s Q1 2026 revenue and EPS?
- Co-Diagnostics, Inc. reported revenue of $146.0K and eps of $-4.06 for Q1 2026.
- Did Co-Diagnostics, Inc. beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $127.1K by $18.9K. EPS missed the consensus estimate of $-3.75 by $0.31.
- How did Co-Diagnostics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 190.3% from $50.3K a year earlier and eps declined 1591.7% from $-0.24.
- Where can I find Co-Diagnostics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-023059) and the 10-K periodic report (0001493152-26-014158) directly on SEC EDGAR. The filing index links above go to sec.gov.
